Award

Cytokine primed autologous Mesenchymal Stromal Cells for therapy of colitis

Description: PUBLIC HEALTH RELEVANCE: Relevance to Public Health: The development of innovative stem cell therapies for inflammatory bowel disease addresses an important unmet medical need. Knowledge gained from the proposed research on mesenchymal stromal cells will lead to practical and effective remedies for Crohn's colitis.

Funder: National Institute of Diabetes and Digestive and Kidney Diseases

Funding type: research

Funder scheme: R01

Start date: 2016-05-01

End date: 2022-04-30

Investigator: JACQUES GALIPEAU

Institution: UNIVERSITY OF WISCONSIN-MADISON

Topic: Mesenchymal stem cell research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

Funded outputs count: 27

Funder award ID: R01DK109508

OpenAlex ID: G1939857825